World Wires · story 126066 · corroborated · 1 source(s)

Nirsevimab effectiveness against RSV hospitalizations in children 8-23 months at risk of severe RSV

Importance: Respiratory syncytial virus (RSV) is a leading cause of hospitalization in high-risk young children during their second RSV season. Nirsevimab,

Open in the desk

Coverage

What this site indexes